| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | Chief Financial Officer | Common Stock | 11,045 | $203,315 | $18.41 | 15 May 2023 | Direct |
| Cibus, Inc. | Director | Class A Common Stock | 0 | $0 | $4.32 | 18 Nov 2024 | Direct |
| 4D Molecular Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 217,060 | 15 May 2023 | Direct | ||
| Cibus, Inc. | Director | Stock Option (Right-to-Buy) | 39,301 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CBUS | Cibus, Inc. | 22 May 2025 | 1 | $0 | 4 | Director | 27 May 2025, 15:22 |
| CBUS | Cibus, Inc. | 20 Nov 2024 | 1 | $0 | 4 | Director | 25 Nov 2024, 16:42 |
| CBUS | Cibus, Inc. | 18 Nov 2024 | 0 | $0 | 3 | Director | 25 Nov 2024, 16:36 |
| FDMT | 4D Molecular Therapeutics, Inc. | 15 May 2023 | 2 | +$28,230 | 4 | Chief Financial Officer | 16 May 2023, 20:52 |
| FDMT | 4D Molecular Therapeutics, Inc. | 10 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 14 Feb 2023, 19:26 |
| FDMT | 4D Molecular Therapeutics, Inc. | 21 Dec 2022 | 2 | +$28,230 | 4 | Chief Financial Officer | 22 Dec 2022, 17:51 |
| FDMT | 4D Molecular Therapeutics, Inc. | 01 Sep 2022 | 1 | $0 | 4 | Chief Financial Officer | 06 Sep 2022, 20:41 |
| FDMT | 4D Molecular Therapeutics Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 03 Feb 2022, 16:43 |